The Young Academic Urologists (YAU) declared Dr. Juan Gómez Rivas (ES) as its new Chairman after online elections were held from 15 to 17 May 2020. About 78 YAU members viewed the candidates’ video presentations and received links where to cast their votes. Dr. Gómez Rivas succeeded Prof. Selçuk Silay (TR) and will serve a four-year term.
In his congratulatory video, Prof. Silay shared his parting words as YAU Chairman to the members: “In YAU, no one is randomly selected. You are chosen because you deserve it, because you have the potential to become one of the future leaders of urology. I believe that many of you will become key opinion leaders. Thank you very much for the support you’ve given. Stay safe and I hope to see you all in person in the near future.”
Meet the new Chairman
Dr. Gómez Rivas is currently a Urology Consultant in the Department of Urology of La Paz University Hospital in Madrid, Spain. His notable contributions to the European Association of Urology (EAU) includes his role as previous Chairman of the European Society of Residents in Urology (ESRU), which represents trainees in urological surgery in the European Union.
Under his leadership, the ESRU was the recipient of the Best Poster Award during EAU Congresses for three years in a row. In addition, Dr. Gómez Rivas and his fellow respected peers wrote “The impact of COVID-19 on European Health Care and Urology Trainees”, an editorial published in the European Urology journal. He stated that “Through publications in scientific journals, we can give voice to the residents.” At present, Dr. Gómez Rivas offers his expertise as an ESRU mentor.
Through the European School of Urology (ESU), he is a valued contributor to undergraduate education. He is a faculty member of the ESU-ESUT-ESUI Masterclass on Focal Therapy for Localised Prostate Cancer and co-authored articles such as “Magnetic resonance as imaging diagnostic tool in prostate cancer: New evidences – The EAU section of uro-technology position”.
In his video presentation, Dr. Gómez Rivas shared some of his many aspirations for the YAU such as the establishment of an intergroup collaboration and platform; optimisation and pooling of diverse capabilities of each group within YAU; and further pursuit of original, prospective and randomised-controlled trials together with the EAU.
Share this on your favourite network: